CSL, UQ vaccine will be more ‘robust’ than rivals
Yolanda RedrupReporterDec 7, 2020 – 11.25amAustralian scientists behind the only locally-developed COVID-19 vaccine candidate concede they trail their rivals but say their product will be a more robust, better long-term option.
Experts from biotechnology giant CSL and the University of Queensland said continued investment in the development of their vaccine as well as emerging therapies was critical to prepare for future pandemics, even as Pfizer’s mRNA-based COVID-19 vaccine began to be rolled out internationally.
https://www.copyright link/companies/healthcare-and-fitness/csl-uq-claim-its-vaccine-could-be-more-robust-than-rivals-20201207-p56l6i
CSL, UQ vaccine will be more ‘robust’ than rivals
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$295.21 |
Change
0.050(0.02%) |
Mkt cap ! $142.6B | |||
| Open | High | Low | Value | Volume |
| $296.30 | $298.20 | $295.00 | $229.6M | 780.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 248 | $295.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $295.21 | 42 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |